In 2015, an estimated 74,000 new cases of bladder cancer are expected to be diagnosed (56,320 in men and 17,680 in women). The predicted mortality for 2015 is 16,000 (11,520 men and 4,480 women). Most bladder cancers occur in people older than 55, with 73 being the average age of diagnosis. During the past 20 years, the incidence of bladder cancer has stabilized, but men continue to be four times more likely to develop bladder cancer than women. Incidence of bladder cancer is twice as high among Caucasians as it is in African-Americans. This CE course provides healthcare professionals with an overview of bladder cancer, including risk factors, signs and symptoms, diagnostic tests, staging and treatment.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Jennifer M.L. Stephens, MA, PhD, RN, OCN, is an oncology nurse with more than a decade of experience in medical/surgical oncology, cancer critical care, bone marrow transplant and hematopoietic stem cell transplantation. Stephens received a PhD in oncology nursing from the University of British Columbia (UBC) in Vancouver and is active with the Canadian Association of Nurses in Oncology (CANO/ACIO) and Oncology Nursing Society (ONS). She has worked as an oncology nurse in the U.S. and Canada, with roles ranging from staff nurse to clinical nurse educator, outpatient clinic coordinator to oncology program manager. She is currently teaching for UBC, Athabasca University, and the British Columbia Institute of Technology (BCIT). Disclosure: Jennifer Stephens, PhD, MA, RN, OCN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.